Courier Capital LLC Amgen Inc Transaction History

Courier Capital LLC

$1.44 Billion
Q3 2024

A detailed history of Courier Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Courier Capital LLC holds 17,537 shares of AMGN stock, worth $4.6 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

17,537

Previous 18,286 4.1%

Holding current value

$4.6 Million

Previous $5.71 Million 1.1%

% of portfolio

0.39%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $231,725 - $252,697	-749 Reduced 4.1%	17,537 $5.65 Million
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $2.74 Million - $3.33 Million	-10,443 Reduced 36.35%	18,286 $5.71 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $535,589 - $646,523	-1,992 Reduced 6.48%	28,729 $8.17 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $993,905 - $1.12 Million	-3,887 Reduced 11.23%	30,721 $8.85 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $132,720 - $164,776	-607 Reduced 1.72%	34,608 $9.3 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $146,346 - $173,051	-683 Reduced 1.9%	35,215 $7.82 Million
Q1 2023 May 18, 2023	SELL	$225.79 - $275.2 $13,321 - $16,236	-59 Reduced 0.16%	35,898 $8.68 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $90,237 - $114,657	-394 Reduced 1.08%	35,957 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $155,550 - $175,432	-693 Reduced 1.87%	36,351 $8.19 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $289,310 - $321,951	-1,254 Reduced 3.27%	37,044 $9.01 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $463,317 - $512,550	-2,113 Reduced 5.23%	38,298 $9.26 Million
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $163,877 - $187,542	-824 Reduced 2.0%	40,411 $9.09 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $21,651 - $25,367	102 Added 0.25%	41,235 $8.77 Million
Q2 2021 Jul 12, 2021	SELL	$233.58 - $259.14 $27,095 - $30,060	-116 Reduced 0.28%	41,133 $10 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $132,702 - $154,642	598 Added 1.47%	41,249 $10.3 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $21,421 - $25,509	-99 Reduced 0.24%	40,651 $9.35 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $435,510 - $484,323	-1,856 Reduced 4.36%	40,750 $9.44 Million
Q2 2020 Jul 06, 2020	SELL	$197.81 - $242.74 $112,949 - $138,604	-571 Reduced 1.32%	42,606 $11 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $1.4 Million - $1.86 Million	-7,705 Reduced 15.14%	43,177 $9.96 Million
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $166,694 - $214,259	-881 Reduced 1.7%	50,882 $12.2 Million
Q3 2019 Oct 04, 2019	BUY	$174.11 - $208.62 $157,047 - $188,175	902 Added 1.77%	51,763 $9.97 Million
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $676,468 - $792,973	4,058 Added 8.67%	50,861 $9.37 Million
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $137,822 - $155,356	-762 Reduced 1.6%	46,803 $8.89 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $179,827 - $209,916	-1,008 Reduced 2.08%	47,565 $9.26 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $204,560 - $230,614	-1,104 Reduced 2.22%	48,573 $10.1 Million
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $106,936 - $120,112	-644 Reduced 1.28%	49,677 $9.17 Million
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $223,139 - $260,766	-1,317 Reduced 2.55%	50,321 $8.58 Million
Q4 2017 Jan 25, 2018	BUY	$168.79 - $188.59 $109,544 - $122,394	649 Added 1.27%	51,638 $8.98 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $5.54 Million - $6.32 Million	33,102 Added 185.06%	50,989 $9.51 Million
Q2 2017 Aug 10, 2017	BUY	N/A	17,887	17,887 $3.08 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Account

Courier Capital LLC Amgen Inc Transaction History